Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.540
-0.040 (-1.55%)
Jul 22, 2026, 11:47 AM EDT - Market open
Cellectar Biosciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cellectar Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $11.5. The average 1-year stock price forecast is 352.76% higher than the current stock price, while the lowest is $10 (+293.70%) and the highest is $15 (+490.55%).
Price Target: $11.5 (+352.76%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cellectar Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 3 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 2 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital Markets | Brookline Capital Markets | Buy Initiates $15 | Buy | Initiates | $15 | +490.55% | Jul 12, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $10 | Buy | Initiates | $10 | +293.70% | May 15, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $10 | Buy | Maintains | $10 | +293.70% | May 15, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $14 → $11 | Buy | Reiterates | $14 → $11 | +333.07% | May 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.65M
EPS This Year
-2.17
from -8.35
EPS Next Year
-1.79
from -2.17
EPS and Forward PE are based on non-GAAP adjusted numbers.